Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2009-01-08
- Lead Sponsor
- Quigley Pharma, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT00568035
- Locations
- 🇺🇸
Parkway Medical Center, Birmingham, Alabama, United States
🇺🇸Seale Harris Clinic / Alliance Clinical Research, Birmingham, Alabama, United States
🇺🇸Pacific Sleep Medicine Services, Inc, Fountain Valley, California, United States
News
No news found